Broadfin Capital Shows New 9.42% Stake in Pernix Therapeutics (PTX)
Tweet Send to a Friend
In a 13G filing on Pernix Therapeutics (NASDAQ: PTX), hedge fund Broadfin ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
